[go: up one dir, main page]

BR9507980A - Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto - Google Patents

Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto

Info

Publication number
BR9507980A
BR9507980A BR9507980A BR9507980A BR9507980A BR 9507980 A BR9507980 A BR 9507980A BR 9507980 A BR9507980 A BR 9507980A BR 9507980 A BR9507980 A BR 9507980A BR 9507980 A BR9507980 A BR 9507980A
Authority
BR
Brazil
Prior art keywords
anxiety
prophylaxis
pharmaceutical composition
compound
disorders associated
Prior art date
Application number
BR9507980A
Other languages
English (en)
Inventor
Wai Ngor Chan
Helen Kate Ann
Mervyn Thompson
John Morris Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411632A external-priority patent/GB9411632D0/en
Priority claimed from GB9411798A external-priority patent/GB9411798D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9507980A publication Critical patent/BR9507980A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
BR9507980A 1994-06-10 1995-05-31 Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto BR9507980A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9411632A GB9411632D0 (en) 1994-06-10 1994-06-10 Novel treatment
GB9411798A GB9411798D0 (en) 1994-06-13 1994-06-13 Novel treatment
PCT/EP1995/002076 WO1995034545A1 (en) 1994-06-10 1995-05-31 Benzopyrans and their use as therapeutic agents

Publications (1)

Publication Number Publication Date
BR9507980A true BR9507980A (pt) 1997-08-12

Family

ID=26305044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507980A BR9507980A (pt) 1994-06-10 1995-05-31 Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto

Country Status (29)

Country Link
US (1) US5760074A (pt)
EP (2) EP0764157B1 (pt)
JP (2) JP3575767B2 (pt)
KR (1) KR100397721B1 (pt)
CN (2) CN1174975C (pt)
AP (1) AP714A (pt)
AT (2) ATE211469T1 (pt)
AU (1) AU701060B2 (pt)
BG (1) BG63339B1 (pt)
BR (1) BR9507980A (pt)
CA (1) CA2192480C (pt)
CY (1) CY2508B1 (pt)
CZ (1) CZ286081B6 (pt)
DE (2) DE69531801T2 (pt)
DK (2) DK0764157T3 (pt)
ES (2) ES2207590T3 (pt)
FI (1) FI120686B (pt)
HK (1) HK1039115B (pt)
HU (1) HUT76136A (pt)
NO (1) NO315651B1 (pt)
NZ (1) NZ287872A (pt)
OA (1) OA10593A (pt)
PL (1) PL188134B1 (pt)
PT (2) PT764157E (pt)
RO (1) RO113463B1 (pt)
SG (1) SG67930A1 (pt)
SI (2) SI0764157T1 (pt)
SK (1) SK281456B6 (pt)
WO (1) WO1995034545A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021780A1 (en) * 1992-12-11 2001-09-13 Smithkline Beecham P.L.C. Pharmaceutical composition containing bicyclic type compounds
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
US6492415B2 (en) * 1996-09-18 2002-12-10 Smithkline Beecham P.L.C. Use of benzopyranols to treat neurological disorders
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
GB0028697D0 (en) * 2000-11-23 2001-01-10 S P A Novel process
GEP20105001B (en) * 2005-04-04 2010-06-10 Takeda Pharmaceuticals Co Preventive or remedy for depression or anxiety neurosis
JP2011522031A (ja) * 2008-06-05 2011-07-28 ミンスター・リサーチ・リミテッド 新規な治療
EP2307004A1 (en) * 2008-06-05 2011-04-13 Minster Research Limited Novel treatments
RU2012124837A (ru) * 2009-12-03 2014-01-10 Проксимэджен ЛТД Лечение аллодинии и гипералгезии
CN102770134A (zh) 2009-12-03 2012-11-07 普罗克西梅根有限公司 传染性失调的治疗
US20140011773A1 (en) 2012-07-03 2014-01-09 Proximagen Limited Pro-drug Compounds
GB201304814D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds
GB201322932D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Pro-drug compounds
GB201322934D0 (en) 2013-12-23 2014-02-12 Proximagen Ltd Prodrug compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
DK0673374T3 (da) * 1992-12-11 2000-07-31 Smithkline Beecham Corp Farmaceutisk præparat, der indeholder bicykliske forbindelsestyper
JPH08505132A (ja) * 1992-12-11 1996-06-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 医薬活性を有する二環式化合物
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
NO965260D0 (no) 1996-12-09
BG63339B1 (bg) 2001-10-31
SK281456B6 (sk) 2001-03-12
CY2508B1 (en) 2005-12-23
CN1234702C (zh) 2006-01-04
DE69531801D1 (de) 2003-10-23
CZ286081B6 (cs) 2000-01-12
AP9600889A0 (en) 1997-01-31
NZ287872A (en) 1998-05-27
PT764157E (pt) 2002-06-28
JP2003238554A (ja) 2003-08-27
CN1154698A (zh) 1997-07-16
ATE250052T1 (de) 2003-10-15
PL188134B1 (pl) 2004-12-31
DE69531801T2 (de) 2004-07-01
DE69524871D1 (de) 2002-02-07
PT1114821E (pt) 2004-02-27
HK1039115A1 (en) 2002-04-12
CN1174975C (zh) 2004-11-10
OA10593A (en) 2002-07-10
SI0764157T1 (en) 2002-06-30
NO965260L (no) 1997-02-06
PL317579A1 (en) 1997-04-14
HU9603415D0 (en) 1997-02-28
SK158796A3 (en) 1997-07-09
CA2192480A1 (en) 1995-12-21
AU701060B2 (en) 1999-01-21
AU2672795A (en) 1996-01-05
CA2192480C (en) 2007-07-24
CZ361796A3 (en) 1997-08-13
BG101040A (en) 1997-08-29
NO315651B1 (no) 2003-10-06
AP714A (en) 1998-12-23
CN1336369A (zh) 2002-02-20
SG67930A1 (en) 1999-10-19
EP0764157B1 (en) 2002-01-02
FI964936A0 (fi) 1996-12-10
WO1995034545A1 (en) 1995-12-21
SI1114821T1 (en) 2004-02-29
ES2170798T3 (es) 2002-08-16
HK1039115B (en) 2004-08-13
HUT76136A (en) 1997-06-30
ES2207590T3 (es) 2004-06-01
DK0764157T3 (da) 2002-04-22
DK1114821T3 (da) 2004-02-02
HK1001286A1 (en) 1998-06-12
EP1114821A1 (en) 2001-07-11
EP1114821B1 (en) 2003-09-17
JPH10501251A (ja) 1998-02-03
DE69524871T2 (de) 2002-08-22
JP3575767B2 (ja) 2004-10-13
KR100397721B1 (ko) 2004-04-28
EP0764157A1 (en) 1997-03-26
FI964936L (fi) 1997-02-06
ATE211469T1 (de) 2002-01-15
US5760074A (en) 1998-06-02
RO113463B1 (ro) 1998-07-30
FI120686B (fi) 2010-01-29

Similar Documents

Publication Publication Date Title
BR9406128A (pt) Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica
BR9507980A (pt) Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto
BR9406566A (pt) Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
BR9509498A (pt) Agente aglutinante uso do mesmo composição farmacêutica e processo para tratamento de uma doença inflamatória autoimune ou uma doença alérgica
BR9407720A (pt) Composto composiçao farmacêutica e processo para a prevençao ou tratamento de pertubaçoes imunorreguladoras ou doenças que compreendem a administraçao do composto
BR9405911A (pt) Processo para a preparaçao de uma composiçao de copolímero em bloco e composiçao de copolímero em bloco
BR9705926A (pt) Composição tópica utilização e processo para limitar diminuir e/ou impedir a transfêrencia de uma composição
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
BR9508586A (pt) Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica
BR9301707A (pt) Processo para incorporacao de um agente clarificador em uma resina poliolefina semi-cristalina e agente clarificador
FI954654L (fi) Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
BR9709915A (pt) Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
EE9900607A (et) Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks
BR9711108A (pt) Compostos que sÆo novos derivados de piperidina 1,4- dissubstitu¡dos composi-Æo farmac-utica e processos para o tratamento ou profilaxia de doen-as associadas com receptores muscarinicos e para a prepara-Æo de derivados de piperidina 1,4- dissubstituidos contendo flÚor
BR9612054A (pt) Processo para a preparação de uma composição ou um componente detergente ou de limpeza granular e a (0) respectiva(0) composição ou componente
BR9604894A (pt) Derivado de acetamida processo para a preparação do mesmo e uma composição farmacêutica contendo o mesmo
FI970920L (fi) Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon
BR9507788A (pt) Composto ou solvato ou sal do mesmo processo para a preparação do composto composição farmacêutica antagonista do receptor de NK3 uso do composto uso do antagonista do receptor de NG3 e processo para o tratamento e/ou profilaxia de distúrbios pulmonares e distúrbios convulsivos
BR9509989A (pt) Processo para fabricar uma escova de abas abrasiva distribuidor de cobertura para utilização com o processo núcleo e escova de abas abrasivas
BR9506581A (pt) Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário
BR9405216A (pt) Processo para preparação de uma alcanona e/ou um alcanol

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FF Decision: intention to grant
FG9A Patent or certificate of addition granted
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 31/05/2015